Lilly is a medicine company turning science into healing to make life better for people around the world.

[Lilly logo and "A Medicine Company" appear over the last scene.] When health is lost, the only thing you want is to get better. In our relentless pursuit to help the most people around the world, our pipeline is focused on the following key areas:

Lilly unites caring with discovery to create medicines that make life better for people around the world

Lilly forener omsorg med innovasjon for å lage medisiner som gjør livet bedre for mennesker rundt om i verden.

Eli Lilly y Compañía es una empresa farmacéutica de alta especialidad fundada en 1876 que trabaja en el desarrollo de tratamientos en múltiples áreas terapéuticas. Diabetes, psoriasis, cáncer de mama, artritis reumatoide, migraña y más.

Lilly's Purpose: Lilly unites caring with discovery to create medicines that make life better for people around the world. Our Values: Three long-established core values guide Lilly in all that we do.

Eli Lilly and Company works tirelessly to develop and deliver trusted medicines that meet real needs. These include Trulicity, Humalog, Alimta, Forteo, Taltz, Humulin, Basaglar, Jardiance, Cyramza, REYVOW, Verzenio, Emgality and more.

Sep 30, 2024 · Learn about Lilly’s Insulin Affordability Solutions. Home. Company. WHO WE ARE. Key Facts; Key Facts. For nearly 150 years, we’ve made significant and game-changing progress on our mission to make life better for people around the world. We’ve remained headquartered in Indianapolis, Indiana, since our founding on May 10, 1876, but our ...

Lilly introduced Iletin ® (animal-source insulin, Lilly), the world's first commercially available insulin product, for the treatment of diabetes - then a fatal disease with no effective treatment options.

INDIANAPOLIS , Jan. 23, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2024 financial results and 2025 financial guidance on Feb. 6, 2025 . Lilly will also conduct a conference call that day with the investment community and media to further detail the